Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTDSP1 | Q9GZU7 | 4/20 | 0.74 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.74 |
| ▸ | CCR6 | P51684 | 2/20 | 0.74 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.74 |
| ▸ | MEN1 | O00255 | 8/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.67 |
| ▸ | CACNA1B | Q00975 | 3/20 | 0.67 |
| ▸ | APBA1 | Q02410 | 3/20 | 0.67 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.67 |
| ▸ | POLB | P06746 | 2/20 | 0.67 |
| ▸ | DUSP3 | P51452 | 2/20 | 0.67 |
| ▸ | USP2 | O75604 | 1/20 | 0.67 |
| ▸ | PKM | P14618 | 1/20 | 0.67 |
| ▸ | APEX1 | P27695 | 3/20 | 0.52 |
| ▸ | PTPN7 | P35236 | 2/20 | 0.52 |
| ▸ | PTPN22 | Q9Y2R2 | 2/20 | 0.52 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.52 |
| ▸ | PTGES | O14684 | 1/20 | 0.52 |
| ▸ | PTPN12 | Q05209 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4551587 | 1.00 | CTDSP1 (0.74) | CTDSP1TDP1CCR6L3MBTL1MEN1 | |
| SCHEMBL4551586 | 1.00 | CTDSP1 (0.74) | CTDSP1TDP1CCR6L3MBTL1MEN1 | |
| SCHEMBL14440266 | 0.87 | TDP1 (0.84) | CTDSP1TDP1CCR6L3MBTL1MEN1 | |
| SCHEMBL2083915 | 0.85 | KMT2A (0.82) | CTDSP1TDP1CCR6L3MBTL1MEN1 | |
| SCHEMBL14440259 | 0.85 | KMT2A (0.82) | CTDSP1TDP1CCR6L3MBTL1MEN1 | |
| SCHEMBL5630999 | 0.85 | TDP1 (1.00) | CTDSP1TDP1CCR6L3MBTL1MEN1 | |
| SCHEMBL5154002 | 0.85 | TDP1 (1.00) | CTDSP1TDP1CCR6L3MBTL1MEN1 | |
| SCHEMBL4551958 | 0.84 | KMT2A (0.75) | CTDSP1TDP1CCR6L3MBTL1MEN1 | |
| SCHEMBL4551957 | 0.84 | KMT2A (0.75) | CTDSP1TDP1CCR6L3MBTL1MEN1 | |
| SCHEMBL4551955 | 0.84 | KMT2A (0.75) | CTDSP1TDP1CCR6L3MBTL1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8188080-B2 | VHR protein tyrosine phosphatase inhibitors, compositions and methods of use | SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) | 2012-05-29 | — | — | US | disclosed |
| US-8188080-B2 | VHR protein tyrosine phosphatase inhibitors, compositions and methods of use | SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) | 2012-05-29 | — | — | US | disclosed |
| US-8188080-B2 | VHR protein tyrosine phosphatase inhibitors, compositions and methods of use | SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) | 2012-05-29 | — | — | US | disclosed |
| US-20090105254-A1 | VHR PROTEIN TYROSINE PHOSPHATASE INHIBITORS, COMPOSITIONS AND METHODS OF USE | BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) | 2009-04-23 | — | — | US | disclosed |
| US-20090105254-A1 | VHR PROTEIN TYROSINE PHOSPHATASE INHIBITORS, COMPOSITIONS AND METHODS OF USE | BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) | 2009-04-23 | — | — | US | disclosed |
| US-20090105254-A1 | VHR PROTEIN TYROSINE PHOSPHATASE INHIBITORS, COMPOSITIONS AND METHODS OF USE | BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) | 2009-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090105254-A1 | VHR PROTEIN TYROSINE PHOSPHATASE INHIBITORS, COMPOSITIONS AND METHODS OF USE | PTPRR, PTPRS, PTPRCAP | CTDSP1 1377/4885TDP1 624/4885CCR6 1620/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.